Sixteen patients with resistant non-Hodgkin's lymphoma were treated with continuous infusions of vincristine (1-2 mg/m2 daily X 2 days) and bleomycin (0.25 mg/kg bolus dose, then 0.25 mg/kg/daily X 5 days). Responding patients received high dose methotrexate (1500 mg/m2) with citrovorum rescue on da
Single high dose-large field irradiation in drug resistant non-Hodgkin's lymphoma
β Scribed by Charles W. Scarantino; Kathryn M. Greven; David H. Buss
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 437 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-nine patients with advanced non-Hodgkin's lymphoma (38 patients with lymphocytic lymphoma and 1 patient with mixed lymphocytic and histiocytic lymphoma) were treated by fractionated low dose whole body irradiation (WBI) with a minimum follow-up of 8 months. Twenty-eight patients had no previo
## Abstract The role of involved field radiation therapy (IFβRT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for nonβHodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IFβRT. A